Barclays PLC boosted its holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO – Free Report) by 251.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange ...

1 Day ORGO 1.27% DJIA -0.07% Russell 2K 0.11% Health Care/Life Sciences -0.90% ...

Organogenesis had a negative return on equity ... cytokines, and growth factors; NuShield, dehydrated placental tissue covering amnion and chorion membranes for spongy/intermediate layer intact ...

Organogenesis Holdings Inc. plans a bio-manufacturing facility at 100 Technology Way, a vacant building that once housed the now-defunct Rubius Therapeutics. The property in February 2023 was ...

PROVIDENCE — Rhode Island Commerce Corporation has granted Organogenesis, a Massachusetts biotech firm, more than $13 million in tax incentives, to support the company’s opening of a new ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...